Effects of food and drug administration warnings on antidepressant use in a national sample
Effects of food and drug administration warnings on antidepressant use in a national sample
复制标题
DOI:
10.1001/archgenpsychiatry.2007.5
复制
发表时间:
2008-01-01
影响因子:
--
通讯作者:
Druss, Benjamin G.
中科院分区:
文献类型:
--
作者:
Olfson, Mark;Marcus, Steven C.;Druss, Benjamin G.
Context: In June 2003, the Food and Drug Administration (FDA) recommended that paroxetine hydrochloride not be used to treat young people because of potential increased risk of suicidal behavior, and in October 2004, the FDA issued a black box warning concerning all antidepressants for youth.Objective: To characterize associations between these warnings and antidepressant use.Design: Interrupted time series analyses of trends in antidepressant use were performed with Medco pharmacy and enrollment data stratified by patient age, sex, antidepressant type, and specialty of the prescribing physician across 3 study periods: prewarning (May 1, 2002 to June 19, 2003), paroxetine warning (June 20, 2003 to October 15, 2004), and black box warning (October 16, 2004 to December 31, 2005).Main Outcome Measures: The rate of antidepressant use, annualized percentage change in rate of antidepressant use, and difference in trend of antidepressant use between consecutive study periods.Results: During the prewarning study period, there was a 36.0% per year (P